HomeCDXS • NASDAQ
add
Codexis Inc
Previous close
$4.91
Day range
$4.68 - $4.96
Year range
$2.53 - $6.08
Market cap
384.51M USD
Avg Volume
798.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 12.83M | 38.33% |
Operating expense | 13.57M | 10.29% |
Net income | -20.64M | 40.87% |
Net profit margin | -160.84 | 57.26% |
Earnings per share | -0.29 | 7.53% |
EBITDA | -15.34M | 12.76% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 90.26M | 21.02% |
Total assets | 148.18M | -4.06% |
Total liabilities | 74.78M | 18.80% |
Total equity | 73.40M | — |
Shares outstanding | 81.38M | — |
Price to book | 5.46 | — |
Return on assets | -29.55% | — |
Return on capital | -37.76% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -20.64M | 40.87% |
Cash from operations | -12.98M | 20.35% |
Cash from investing | 1.53M | 238.48% |
Cash from financing | 30.31M | 28,161.11% |
Net change in cash | 18.85M | 207.63% |
Free cash flow | -8.02M | -2.38% |
About
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications. Wikipedia
CEO
Founded
2002
Headquarters
Website
Employees
174
